Apyx Medical Corp. (APYX) Reports In-Line Q4 EPS

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $5.76 million.

GUIDANCE:

Apyx Medical Corp. sees FY2019 revenue of $25-26 million, versus the consensus of $25.88 million.

• GAAP net loss in the range of $24.0 million to $23.0 million, compared to GAAP net loss from continuing operations of $9.5 million in fiscal year 2018.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'